Delivery Order SPE2DB22D3016-SPE2DB24FAKJ6
Award Date 1/24/24
Potential Completion Date 2/14/24
Potential Value $58K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,642.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,609,986 units of BOTOX 200 unit vials. This delivery order contract has a completion date of March 1, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX medication. The award, valued at $11,642.60, has a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,288 units of BOTOX 200 UNIT VIALS. The award, valued at $40,749.10, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense, and has received multiple federal contract awards to supply medicines,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,230,046 units of BOTOX 200 unit vials. The $11,642.60 contract has a completion date of January 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 200 unit vials of Botox. The $2,910.65 contract has a performance period through March 4, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) previously...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 unit vials of BOTOX. This $29,106.50 contract has a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,719,032 units of BOTOX 200 unit vials. The $13,971.12 contract has a completion date of March 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is known to hold an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,667,812 units of BOTOX 200 unit vials. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $2,910.65 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 200-unit vials of the pharmaceutical product Botox, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAKJ6Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $58,213.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,439,405 vials of BOTOX 200 unit. The delivery order is in support of DLA Troop Support Medical programs and facilities, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received multiple contracts from DLA to provide pharmaceuticals, medical supplies, and distribution services. The award does not have a set-aside designation.
Generated 4/24/24, 12:19 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.2k | 1/24/24 |